Diaceutics's market cap is currently $152.05M. The company's EPS TTM is $-0.042; its P/E ratio is ―; Diaceutics is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	£ 23.70M	£ 19.50M	£ 13.94M	£ 12.70M	£ 13.44M
Gross Profit	£ 19.71M	£ 14.04M	£ 10.57M	£ 9.33M	£ 10.31M
Operating Income	£ -2.72M	£ 331.00K	£ 313.00K	£ -610.00K	£ 2.12M
EBITDA	£ 2.36M	£ 3.61M	£ 2.11M	£ 178.00K	£ 847.58K
Net Income	£ -1.75M	£ 724.00K	£ 561.00K	£ 263.00K	£ 398.00K
Balance Sheet
Cash & Short-Term Investments	£ 16.67M	£ 19.84M	£ 19.68M	£ 25.25M	£ 11.72M
Total Assets	£ 46.34M	£ 48.26M	£ 45.01M	£ 43.52M	£ 22.37M
Total Debt	£ 1.21M	£ 1.33M	£ 1.56M	£ 118.00K	£ 107.50K
Net Debt	£ -15.46M	£ -18.51M	£ -18.11M	£ -25.14M	£ -11.61M
Total Liabilities	£ 5.56M	£ 5.74M	£ 4.36M	£ 3.28M	£ 2.24M
Stockholders' Equity	£ 40.79M	£ 42.51M	£ 40.65M	£ 40.24M	£ 20.13M
Cash Flow
Free Cash Flow	£ -3.54M	£ 278.00K	£ -5.03M	£ -6.04M	£ -3.55M
Operating Cash Flow	£ 1.31M	£ 5.15M	£ 570.00K	£ 253.00K	£ -627.05K
Investing Cash Flow	£ -4.21M	£ -4.87M	£ -5.60M	£ -6.29M	£ -2.93M
Financing Cash Flow	£ -239.00K	£ -132.00K	£ -270.00K	£ 19.61M	£ 13.29M

Currency in GBP

Diaceutics Earnings and Revenue History

Income Statement >

Diaceutics Debt to Assets

Balance Sheet >

Diaceutics Cash Flow

Cash Flow >

Diaceutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing